|
Re: China- 1 Million daily COVID cases
|
6
|
Resverlogix Corp.
|
Dec 30, 2022 08:52AM
|
|
Re: CityNews cover
|
5
|
Resverlogix Corp.
|
Jan 31, 2022 02:29PM
|
|
Re: CityNews cover
|
1
|
Resverlogix Corp.
|
Jan 31, 2022 05:17PM
|
|
Re: CityNews cover
|
3
|
Resverlogix Corp.
|
Jan 31, 2022 01:01PM
|
|
Re: Civil vs. criminal court judgments
|
|
Resverlogix Corp.
|
Dec 17, 2019 11:26AM
|
|
Re: CKD Reata / Market Cap
|
1
|
Resverlogix Corp.
|
May 05, 2019 11:22AM
|
|
Re: CKD Reata / Market Cap
|
1
|
Resverlogix Corp.
|
May 04, 2019 11:12AM
|
|
Re: CKD Reata / Market Cap
|
1
|
Resverlogix Corp.
|
May 04, 2019 11:50AM
|
|
Re: Clarification on BETonMACE baseline data
|
|
Resverlogix Corp.
|
Sep 05, 2019 04:35PM
|
|
Re: Clarification on BETonMACE baseline data
|
|
Resverlogix Corp.
|
Sep 05, 2019 05:48PM
|
|
Re: Clarification on BETonMACE baseline data
|
1
|
Resverlogix Corp.
|
Sep 04, 2019 01:57PM
|
|
Re: Clarification on BETonMACE baseline data
|
1
|
Resverlogix Corp.
|
Sep 04, 2019 03:12PM
|
|
Re: Clarification on BETonMACE baseline data
|
1
|
Resverlogix Corp.
|
Sep 04, 2019 04:00PM
|
|
Re: Class B Preferred Shares Issued
|
1
|
Resverlogix Corp.
|
Mar 13, 2020 02:42PM
|
|
Re: Clinical trials query results
|
3
|
Zenith Epigenetics
|
Apr 08, 2021 11:41AM
|
|
Re: Clinical trials site
|
5
|
Zenith Epigenetics
|
Aug 20, 2022 07:05AM
|
|
Re: Clinical trials site
|
3
|
Zenith Epigenetics
|
Aug 20, 2022 07:25AM
|
|
Re: Clinical trials site
|
5
|
Zenith Epigenetics
|
Aug 20, 2022 08:34AM
|
|
Re: Close competitor…
|
|
Resverlogix Corp.
|
Oct 19, 2021 09:43AM
|
|
Re: Close competitor…
|
4
|
Resverlogix Corp.
|
Oct 21, 2021 11:05AM
|
